Abiopharma

News list

Mayes Patrick A 🟡 adjusted position in 2.2K shares (1 derivative) of INCYTE CORP (INCY) at $123.99 Transaction Date: Aug 05, 2026 | Filing ID: 000015

Full text

News bot Aug. 7, 2026, 8:02 p.m.
🔍 Mayes Patrick A (Executive)

Company: INCYTE CORP (INCY)

Report Date: 2026-08-05
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,207
- Total shares sold: 4,414
Detailed Transactions and Holdings:
- Acquired 2,207 shares of Common Stock at $106.47 per share (Direct)
  Date: 2026-08-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 63,648.00 | transaction_form_type: 4
- Sold 2,207 shares of Common Stock at $123.99 per share (Direct)
  Date: 2026-08-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 61,441.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,207 shares of Employee Stock Option (right to buy) at $106.47 per share (Derivative)
  Date: 2026-08-05 | Code: M | Expires: 2030-07-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.
- F2: As of August 5th, 2026, the award is fully vested and exercisable